MEC Plus Full List View

MEC Plus

Burkitt Lymphoma
Burkitt Lymphoma
Leidy Isenalumhe, MD
Double Hit Lymphomas
Double Hit Lymphomas
Julio Chavez, MD, MS
CNS Lymphomas
CNS Lymphomas
Sepideh Mokhtari, MD
Current Standard of Therapies in CLL
Current Standard of Therapies in CLL
Javier Pinilla-Ibarz, MD, PhD
New Therapies for Follicular Lymphoma
New Therapies for Follicular Lymphoma
Sameh Gaballa, MD
The Rule of Immunotherapy in the Treatment of Relapse Hodgkin Lymphoma
The Rule of Immunotherapy in the Treatment of Relapse Hodgkin Lymphoma
Hayder Saeed, MD
New Strategies for MCL
New Strategies for MCL
Bijal Shah, MD, MS
Marginal Zone Lymphomas
Marginal Zone Lymphomas
Sameh Gaballa, MD
DLBCL: Current Therapeutic Approaches
DLBCL: Current Therapeutic Approaches
Julio Chavez, MD, MS
PTCL: Evolving targeted therapies for mature T cell lymphoma
PTCL: Evolving targeted therapies for mature T cell lymphoma
Hayder Saeed, MD
CTCL: Micosis Fungoides & Sezary Syndrome
CTCL: Micosis Fungoides & Sezary Syndrome
Lubomir Sokol, MD, PhD
CDK4/6, PIK3CA & PARP Inhibitors in MBCA
CDK4/6, PIK3CA & PARP Inhibitors in MBCA
Stephanie L. Graff, MD
Endocrine Therapy in the Neoadjuvant & Adjuvant Setting
Endocrine Therapy in the Neoadjuvant & Adjuvant Setting
Vicente Valero, MD
HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics
HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics
Jane Lowe Meisel, MD
Breast Cancer Immunotherapy
Breast Cancer Immunotherapy
Joyce O’Shaugnessy, MD
Breast Cancer Immunotherapy
Breast Cancer Immunotherapy
Joyce O’Shaugnessy, MD